Validation of risk stratification and novel prognostic biomarkers in asian adult HSCT recipients with TA-TMA: A multicenter real-world study.
Saved in:
| Title: | Validation of risk stratification and novel prognostic biomarkers in asian adult HSCT recipients with TA-TMA: A multicenter real-world study. |
|---|---|
| Authors: | Wu Y; Bone Marrow Transplantation Center of the First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China.; Institute of Hematology, Zhejiang University, Hangzhou, China.; Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, Hangzhou, China., Yuan X; Department of Hematology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, China., Chen L; Bone Marrow Transplantation Center of the First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China.; Department of Hematology, The First Affiliated Hospital of Ningbo University, Ningbo, China., Lai X; Bone Marrow Transplantation Center of the First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China.; Institute of Hematology, Zhejiang University, Hangzhou, China.; Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, Hangzhou, China., Liu L; Bone Marrow Transplantation Center of the First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China.; Institute of Hematology, Zhejiang University, Hangzhou, China.; Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, Hangzhou, China., Yang L; Bone Marrow Transplantation Center of the First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China.; Institute of Hematology, Zhejiang University, Hangzhou, China.; Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, Hangzhou, China., Shi J; Bone Marrow Transplantation Center of the First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China.; Institute of Hematology, Zhejiang University, Hangzhou, China.; Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, Hangzhou, China., Yu J; Bone Marrow Transplantation Center of the First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China.; Institute of Hematology, Zhejiang University, Hangzhou, China.; Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, Hangzhou, China., Zhao Y; Bone Marrow Transplantation Center of the First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China.; Institute of Hematology, Zhejiang University, Hangzhou, China.; Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, Hangzhou, China., Ouyang G; Department of Hematology, The First Affiliated Hospital of Ningbo University, Ningbo, China., Ni L; Department of Hematology, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China., Xiao H; Department of Hematology and Cell Therapy, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China., Xu Y; Department of Hematology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China., Tang L; Department of Hematology, Luoyang Central Hospital Affiliated to Zhengzhou University, Luoyang, China., Zhu P; Bone Marrow Transplantation Center of the First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China.; Institute of Hematology, Zhejiang University, Hangzhou, China.; Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, Hangzhou, China., Cai Z; Bone Marrow Transplantation Center of the First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China.; Institute of Hematology, Zhejiang University, Hangzhou, China.; Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, Hangzhou, China., Huang H; Bone Marrow Transplantation Center of the First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China.; Institute of Hematology, Zhejiang University, Hangzhou, China.; Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, Hangzhou, China., Lu Y; Department of Hematology, The Affiliated Peoples' Hospital of Ningbo University, Ningbo, China., Luo Y; Bone Marrow Transplantation Center of the First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China. luoyijr@zju.edu.cn.; Institute of Hematology, Zhejiang University, Hangzhou, China. luoyijr@zju.edu.cn.; Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, Hangzhou, China. luoyijr@zju.edu.cn. |
| Source: | Bone marrow transplantation [Bone Marrow Transplant] 2026 Apr; Vol. 61 (4), pp. 408-416. Date of Electronic Publication: 2026 Jan 09. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5365 (Electronic) Linking ISSN: 02683369 NLM ISO Abbreviation: Bone Marrow Transplant Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41514049 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Validation of risk stratification and novel prognostic biomarkers in asian adult HSCT recipients with TA-TMA: A multicenter real-world study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Wu+Y%22">Wu Y</searchLink>; Bone Marrow Transplantation Center of the First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China.; Institute of Hematology, Zhejiang University, Hangzhou, China.; Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, Hangzhou, China.<br /><searchLink fieldCode="AU" term="%22Yuan+X%22">Yuan X</searchLink>; Department of Hematology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, China.<br /><searchLink fieldCode="AU" term="%22Chen+L%22">Chen L</searchLink>; Bone Marrow Transplantation Center of the First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China.; Department of Hematology, The First Affiliated Hospital of Ningbo University, Ningbo, China.<br /><searchLink fieldCode="AU" term="%22Lai+X%22">Lai X</searchLink>; Bone Marrow Transplantation Center of the First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China.; Institute of Hematology, Zhejiang University, Hangzhou, China.; Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, Hangzhou, China.<br /><searchLink fieldCode="AU" term="%22Liu+L%22">Liu L</searchLink>; Bone Marrow Transplantation Center of the First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China.; Institute of Hematology, Zhejiang University, Hangzhou, China.; Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, Hangzhou, China.<br /><searchLink fieldCode="AU" term="%22Yang+L%22">Yang L</searchLink>; Bone Marrow Transplantation Center of the First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China.; Institute of Hematology, Zhejiang University, Hangzhou, China.; Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, Hangzhou, China.<br /><searchLink fieldCode="AU" term="%22Shi+J%22">Shi J</searchLink>; Bone Marrow Transplantation Center of the First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China.; Institute of Hematology, Zhejiang University, Hangzhou, China.; Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, Hangzhou, China.<br /><searchLink fieldCode="AU" term="%22Yu+J%22">Yu J</searchLink>; Bone Marrow Transplantation Center of the First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China.; Institute of Hematology, Zhejiang University, Hangzhou, China.; Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, Hangzhou, China.<br /><searchLink fieldCode="AU" term="%22Zhao+Y%22">Zhao Y</searchLink>; Bone Marrow Transplantation Center of the First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China.; Institute of Hematology, Zhejiang University, Hangzhou, China.; Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, Hangzhou, China.<br /><searchLink fieldCode="AU" term="%22Ouyang+G%22">Ouyang G</searchLink>; Department of Hematology, The First Affiliated Hospital of Ningbo University, Ningbo, China.<br /><searchLink fieldCode="AU" term="%22Ni+L%22">Ni L</searchLink>; Department of Hematology, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, China.<br /><searchLink fieldCode="AU" term="%22Xiao+H%22">Xiao H</searchLink>; Department of Hematology and Cell Therapy, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.<br /><searchLink fieldCode="AU" term="%22Xu+Y%22">Xu Y</searchLink>; Department of Hematology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.<br /><searchLink fieldCode="AU" term="%22Tang+L%22">Tang L</searchLink>; Department of Hematology, Luoyang Central Hospital Affiliated to Zhengzhou University, Luoyang, China.<br /><searchLink fieldCode="AU" term="%22Zhu+P%22">Zhu P</searchLink>; Bone Marrow Transplantation Center of the First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China.; Institute of Hematology, Zhejiang University, Hangzhou, China.; Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, Hangzhou, China.<br /><searchLink fieldCode="AU" term="%22Cai+Z%22">Cai Z</searchLink>; Bone Marrow Transplantation Center of the First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China.; Institute of Hematology, Zhejiang University, Hangzhou, China.; Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, Hangzhou, China.<br /><searchLink fieldCode="AU" term="%22Huang+H%22">Huang H</searchLink>; Bone Marrow Transplantation Center of the First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China.; Institute of Hematology, Zhejiang University, Hangzhou, China.; Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, Hangzhou, China.<br /><searchLink fieldCode="AU" term="%22Lu+Y%22">Lu Y</searchLink>; Department of Hematology, The Affiliated Peoples' Hospital of Ningbo University, Ningbo, China.<br /><searchLink fieldCode="AU" term="%22Luo+Y%22">Luo Y</searchLink>; Bone Marrow Transplantation Center of the First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China. luoyijr@zju.edu.cn.; Institute of Hematology, Zhejiang University, Hangzhou, China. luoyijr@zju.edu.cn.; Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, Hangzhou, China. luoyijr@zju.edu.cn. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228702459%22">Bone marrow transplantation</searchLink> [Bone Marrow Transplant] 2026 Apr; Vol. 61 (4), pp. 408-416. <i>Date of Electronic Publication: </i>2026 Jan 09. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Multicenter Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8702459 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-5365 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2202683369%22">02683369 </searchLink><i>NLM ISO Abbreviation: </i>Bone Marrow Transplant <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41514049 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41409-025-02777-x Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 408 Titles: – TitleFull: Validation of risk stratification and novel prognostic biomarkers in asian adult HSCT recipients with TA-TMA: A multicenter real-world study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Wu Y – PersonEntity: Name: NameFull: Yuan X – PersonEntity: Name: NameFull: Chen L – PersonEntity: Name: NameFull: Lai X – PersonEntity: Name: NameFull: Liu L – PersonEntity: Name: NameFull: Yang L – PersonEntity: Name: NameFull: Shi J – PersonEntity: Name: NameFull: Yu J – PersonEntity: Name: NameFull: Zhao Y – PersonEntity: Name: NameFull: Ouyang G – PersonEntity: Name: NameFull: Ni L – PersonEntity: Name: NameFull: Xiao H – PersonEntity: Name: NameFull: Xu Y – PersonEntity: Name: NameFull: Tang L – PersonEntity: Name: NameFull: Zhu P – PersonEntity: Name: NameFull: Cai Z – PersonEntity: Name: NameFull: Huang H – PersonEntity: Name: NameFull: Lu Y – PersonEntity: Name: NameFull: Luo Y IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 04 Text: 2026 Apr Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1476-5365 Numbering: – Type: volume Value: 61 – Type: issue Value: 4 Titles: – TitleFull: Bone marrow transplantation Type: main |
| ResultId | 1 |